These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 28510612)

  • 21. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.
    Salonga D; Danenberg KD; Johnson M; Metzger R; Groshen S; Tsao-Wei DD; Lenz HJ; Leichman CG; Leichman L; Diasio RB; Danenberg PV
    Clin Cancer Res; 2000 Apr; 6(4):1322-7. PubMed ID: 10778957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined evaluation of dihydropyrimidine dehydrogenase and thymidine phosphorylate mRNA levels in tumor predicts the histopathological effect of 5-fluorouracil-based chemoradiotherapy.
    Tateishi Y; Tatemoto Y; Ohno S; Morishita K; Ueta E; Yamamoto T
    Cancer Lett; 2009 Feb; 274(2):187-93. PubMed ID: 18986760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymidine phosphorylase mRNA level predicts survival of patients with advanced oropharyngeal cancer.
    Ijuin T; Nibu K; Doi K; Inoue H; Saitoh M; Ohtsuki N; Makino K; Amatsu M
    Acta Otolaryngol; 2007 Mar; 127(3):305-11. PubMed ID: 17364369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expression in primary colorectal tumors-correlation to tumor histopathology and clinical follow-up.
    Lassmann S; Hennig M; Rosenberg R; Nährig J; Schreglmann J; Krause F; Poignee-Heger M; Nekarda H; Höfler H; Werner M
    Int J Colorectal Dis; 2006 Apr; 21(3):238-47. PubMed ID: 16132996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular determinants of efficacy for 5-FU-based treatments in advanced colorectal cancer: mRNA expression for 18 chemotherapy-related genes.
    Gustavsson B; Kaiser C; Carlsson G; Wettergren Y; Odin E; Lindskog EB; Niyikiza C; Ma D
    Int J Cancer; 2009 Mar; 124(5):1220-6. PubMed ID: 19051292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein-bound polysaccharide-K augments the anticancer effect of fluoropyrimidine derivatives possibly by lowering dihydropyrimidine dehydrogenase expression in gastrointestinal cancers.
    Mekata E; Murata S; Sonoda H; Shimizu T; Umeda T; Shiomi H; Naka S; Yamamoto H; Abe H; Edamatsu T; Fujieda A; Fujioka M; Wada T; Tani T
    Oncol Rep; 2013 Dec; 30(6):2845-51. PubMed ID: 24100378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of heat shock protein 27 expression promotes 5-fluorouracil sensitivity in colon cancer cells in a xenograft model.
    Hayashi R; Ishii Y; Ochiai H; Matsunaga A; Endo T; Hasegawa H; Kitagawa Y
    Oncol Rep; 2012 Oct; 28(4):1269-74. PubMed ID: 22842517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gossypol sensitizes the antitumor activity of 5-FU through down-regulation of thymidylate synthase in human colon carcinoma cells.
    Yang D; Qu J; Qu X; Cao Y; Xu L; Hou K; Feng W; Liu Y
    Cancer Chemother Pharmacol; 2015 Sep; 76(3):575-86. PubMed ID: 26208739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor 5-FU-related mRNA Expression and Efficacy of Oral Fluoropyrimidines in Adjuvant Chemotherapy of Colorectal Cancer.
    Koda K; Miyauchi H; Kosugi C; Kaiho T; Takiguchi N; Kobayashi S; Maruyama T; Matsubara H;
    Anticancer Res; 2016 Oct; 36(10):5325-5331. PubMed ID: 27798895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deciphering the potential value of 5-fluorouracil metabolic enzymes in predicting prognosis and treatment response of colorectal cancer patients.
    Gajjar KK; Vora HH; Kobawala TP; Trivedi TI; Ghosh NR
    Int J Biol Markers; 2018 May; 33(2):180-188. PubMed ID: 29799355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis.
    Inokuchi M; Uetake H; Shirota Y; Yamada H; Tajima M; Sugihara K
    Cancer Chemother Pharmacol; 2004 May; 53(5):391-6. PubMed ID: 15060742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between mRNA expression of chemotherapy-related genes and clinicopathological features in colorectal cancer: A large-scale population analysis.
    Shimamoto Y; Nukatsuka M; Takechi T; Fukushima M
    Int J Mol Med; 2016 Feb; 37(2):319-28. PubMed ID: 26676887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The upregulation of dihydropyrimidine dehydrogenase in liver is involved in acquired resistance to 5-fluorouracil.
    Li LH; Dong H; Zhao F; Tang J; Chen X; Ding J; Men HT; Luo WX; Du Y; Ge J; Tan BX; Cao D; Liu JY
    Eur J Cancer; 2013 May; 49(7):1752-60. PubMed ID: 23313143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in esophageal carcinoma cell lines.
    Ando T; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Sugito N; Mori R; Ogawa R; Katada T; Fujii Y
    Dis Esophagus; 2008; 21(1):15-20. PubMed ID: 18197934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin.
    Han J; Li J; Tang K; Zhang H; Guo B; Hou N; Huang C
    Exp Cell Res; 2017 Nov; 360(2):328-336. PubMed ID: 28928082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase mRNA expression correlate with prolonged survival in resected non-small-cell lung cancer.
    Grimminger PP; Schneider PM; Metzger R; Vallböhmer D; Hölscher AH; Danenberg PV; Brabender J
    Clin Lung Cancer; 2010 Sep; 11(5):328-34. PubMed ID: 20837458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consensus interferon enhances the anti-proliferative effect of 5-fluorouracil on human hepatoma cells via downregulation of dihydropyrimidine dehydrogenase expression.
    Dou J; Iwashita Y; Sasaki A; Kai S; Hirano S; Ohta M; Kitano S
    Liver Int; 2005 Feb; 25(1):148-52. PubMed ID: 15698412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NK4 regulates 5-fluorouracil sensitivity in cholangiocarcinoma cells by modulating the intrinsic apoptosis pathway.
    Ge X; Wang Y; Li Q; Yu H; Ji G; Miao L
    Oncol Rep; 2013 Jul; 30(1):448-54. PubMed ID: 23619566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Level of
    Przybyla T; Wesserling M; Sakowicz-Burkiewicz M; Maciejewska I; Pawelczyk T
    Saudi J Gastroenterol; 2018; 24(1):37-45. PubMed ID: 29451183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between clinicopathologic factors and kinetics of metabolic enzymes for 5-fluorouracil given to patients with colon carcinoma by two different dosage regimens.
    Katsumata K; Tomioka H; Sumi T; Yamashita S; Takagi M; Kato F; Nakamura R; Koyanagi Y; Aoki T; Kato K
    Cancer Chemother Pharmacol; 2003 Feb; 51(2):155-60. PubMed ID: 12647017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.